GHSI: Guardion Health Sciences Company Aggregate Debts

Guardion Health Science (GHSI) develops nutraceuticals and therapeutic nutrition for vision, leveraging sales through pharmacies, clinics, and online stores to minimize risks. This daily price chart reflects the dynamics of a specific debt, which currently stands at 0.00. Meanwhile, the brand is implementing ESG principles by transitioning to biodegradable packaging and partnering with raw material suppliers that maintain minimal carbon emissions.

Total borrowings reflect the balance between financial stability and the use of leverage to scale the business. This metric aggregates all company liabilities, while the total debt history demonstrates the ability of Guardion Health Science (GHSI) management to finance environmental production upgrades and ESG raw material purification standards without creating critical default risks.